Showing results (231-240 of 240) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 240 results.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 28, 2017
Endothelial HIF-2α contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transitionHaiyang Tang, Aleksandra Babicheva, Kimberly M McDermott, et al.
American Journal of Respiratory Cell and Molecular Biology|November 9, 2017
LPS-induced Acute Lung Injury Involves NF-κB-mediated Downregulation of SOX18Christine M Gross, Manuela Kellner, Ting Wang, et al.
The Journal of Clinical Investigation|June 25, 2014
Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertensionThomas Bertero, Yu Lu, Sofia Annis, et al.
American Journal of Physiology. Cell Physiology|October 20, 2021
Endothelial upregulation of mechanosensitive channel Piezo1 in pulmonary hypertensionZiyi Wang, Jiyuan Chen, Aleksandra Babicheva, et al.
Annals of the American Thoracic Society|June 2, 2017
An Official American Thoracic Society Workshop Report: Obesity and Metabolism. An Emerging Frontier in Lung Health and DiseaseBenjamin T Suratt, Niki D J Ubags, Deepa Rastogi, et al.
British Journal of Pharmacology|January 25, 2020
Tetramethylpyrazine: A promising drug for the treatment of pulmonary hypertensionYuqin Chen, Wenju Lu, Kai Yang, et al.
Angiogenesis|November 13, 2022
Inflammation and vascular remodeling in COVID-19 heartsChristopher Werlein, Maximilian Ackermann, Helge Stark, et al.
Cell Reports|November 14, 2015
Matrix Remodeling Promotes Pulmonary Hypertension through Feedback Mechanoactivation of the YAP/TAZ-miR-130/301 CircuitThomas Bertero, Katherine A Cottrill, Yu Lu, et al.
American Journal of Respiratory and Critical Care Medicine|March 13, 2023
SOX17 Deficiency Mediates Pulmonary Hypertension: At the Crossroads of Sex, Metabolism, and GeneticsShreya Sangam, Xutong Sun, Tae-Hwi Schwantes-An, et al.
Ebiomedicine|October 7, 2022
The fatal trajectory of pulmonary COVID-19 is driven by lobular ischemia and fibrotic remodellingMaximilian Ackermann, Jan C Kamp, Christopher Werlein, et al.
Pageof 24